BioLineRx (BLRX) EBIT (QoQ) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -53.42% |
| Sep 30, 2025 | 4.17% |
| Jun 30, 2025 | 3.68% |
| Mar 31, 2025 | 45.98% |
| Dec 31, 2024 | 17.84% |
| Sep 30, 2024 | 6.69% |
| Jun 30, 2024 | -19.72% |
| Mar 31, 2024 | 74.03% |
| Dec 31, 2023 | -50.25% |
| Sep 30, 2023 | -24.63% |
| Jun 30, 2023 | -11.96% |
| Mar 31, 2023 | -5.45% |
| Dec 31, 2022 | -18.65% |
| Sep 30, 2022 | 6.89% |
| Jun 30, 2022 | -25.05% |
| Mar 31, 2022 | 7.87% |
| Dec 31, 2021 | -6.13% |
| Sep 30, 2021 | 4.54% |
| Jun 30, 2021 | -19.53% |
| Mar 31, 2021 | 7.20% |
| Dec 31, 2020 | -26.31% |
| Sep 30, 2020 | 16.48% |
| Jun 30, 2020 | 18.63% |
| Mar 31, 2020 | 27.33% |
| Dec 31, 2019 | -41.70% |
| Sep 30, 2019 | -2.56% |
| Jun 30, 2019 | -16.12% |
| Mar 31, 2019 | 20.73% |
| Dec 31, 2018 | -13.28% |
| Sep 30, 2018 | -8.47% |
| Jun 30, 2018 | 13.61% |
| Mar 31, 2018 | 13.77% |
| Dec 31, 2017 | -8.94% |
| Sep 30, 2017 | -35.87% |
| Jun 30, 2017 | 2.02% |
| Mar 31, 2017 | -20.92% |
| Dec 31, 2016 | 2.32% |
| Sep 30, 2016 | -16.09% |
| Jun 30, 2016 | -2.38% |
| Mar 31, 2016 | 7.90% |
| Dec 31, 2015 | -13.79% |
| Sep 30, 2015 | 13.51% |
| Jun 30, 2015 | 3.72% |
| Mar 31, 2015 | 16.74% |
| Dec 31, 2014 | -27.66% |
| Sep 30, 2014 | -4.09% |
| Jun 30, 2014 | 4.05% |
| Mar 31, 2014 | -78.30% |
| Dec 31, 2013 | 30.20% |
| Sep 30, 2013 | 29.28% |
| Jun 30, 2013 | 28.82% |